Royalty Pharma raises bid for Elan Royalty Pharma today raised its hostile bid for Elan to a potential $8 billion, coming back for the third time after just 7.5% of shareholders accepted the last offer. Business • 07 Jun 13
Royalty Pharma raises bid for Elan Royalty Pharma today raised its hostile bid for Elan to a potential $8 billion, coming back for the third time after just 7.5% of shareholders accepted the last offer. Business • 07 Jun 13
Elan has 'Plan B' if shareholders reject deals Elan said it will lay out an alternative strategy if shareholders reject a string of planned deals. Business • 30 May 13
Elan has 'Plan B' if shareholders reject deals Elan said it will lay out an alternative strategy if shareholders reject a string of planned deals. Business • 30 May 13
Apple sells $17 billion in bonds in record deal Apple sold $17 billion in bonds last night in a record deal spurred by the company's plan to placate its frustrated shareholders. Business • 01 May 13
Apple sells $17 billion in bonds in record deal Apple sold $17 billion in bonds last night in a record deal spurred by the company's plan to placate its frustrated shareholders. Business • 01 May 13
